BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38634345)

  • 1. Anti-D immunization after D positive platelet transfusions in D negative recipients: A systematic review and meta-analysis.
    Hubert T; Kerkhoffs JL; Brand A; Schonewille H
    Transfusion; 2024 May; 64(5):933-945. PubMed ID: 38634345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study.
    Cid J; Lozano M; Ziman A; West KA; O'Brien KL; Murphy MF; Wendel S; Vázquez A; Ortín X; Hervig TA; Delaney M; Flegel WA; Yazer MH;
    Br J Haematol; 2015 Feb; 168(4):598-603. PubMed ID: 25283094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D+ platelet transfusions in D- patients: cause for concern?
    Bartley AN; Carpenter JB; Berg MP
    Immunohematology; 2009; 25(1):5-8. PubMed ID: 19856725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transfusions of rhesus-incompatible platelet concentrates in Rouen University Hospital: procedures and consequences].
    Chamouni P; Josset V; Bastit D; Tavolacci MP; Lenain P; Varin R; Czernichow P
    Transfus Clin Biol; 2005 Oct; 12(4):306-12. PubMed ID: 16169273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Platelet transfusion and immunization anti-Rh1: implication for immunoprophylaxis].
    Chambost H
    Transfus Clin Biol; 2014 Nov; 21(4-5):210-5. PubMed ID: 25282489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of D alloimmunization in D- pediatric oncology patients receiving D-incompatible single-donor platelets.
    Molnar R; Johnson R; Sweat LT; Geiger TL
    Transfusion; 2002 Feb; 42(2):177-82. PubMed ID: 11896332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions.
    Cid J; Ortin X; Elies E; Castellà D; Panadés M; Martín-Vega C
    Transfusion; 2002 Feb; 42(2):173-6. PubMed ID: 11896331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-D alloimmunization after D-incompatible platelet transfusions: a 14-year single-institution retrospective review.
    O'Brien KL; Haspel RL; Uhl L
    Transfusion; 2014 Mar; 54(3):650-4. PubMed ID: 23829356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet transfusions from D+ donors to D- patients: a 10-year follow-up study of 1014 patients.
    Cid J; Carbassé G; Pereira A; Sanz C; Mazzara R; Escolar G; Lozano M
    Transfusion; 2011 Jun; 51(6):1163-9. PubMed ID: 21126258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell alloimmunisation after platelet transfusion (excluding ABO blood group system).
    Moncharmont P
    Transfus Clin Biol; 2020 Aug; 27(3):185-190. PubMed ID: 32544526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitigation strategies for anti-D alloimmunization by platelet transfusion in haematopoietic stem cell transplant patients: a survey of NCCN
    Poston JN; Sugalski J; Gernsheimer TB; Marc Stewart F; Pagano MB
    Vox Sang; 2020 May; 115(4):334-338. PubMed ID: 32080868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions.
    Karafin MS; Blagg L; Tobian AA; King KE; Ness PM; Savage WJ
    Transfusion; 2012 Oct; 52(10):2087-93. PubMed ID: 22339320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet transfusion and respecting patient D type.
    Cid J; Yazer MH; Lozano M
    Curr Opin Hematol; 2015 Nov; 22(6):540-6. PubMed ID: 26414185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of Rh prophylaxis.
    Berger GS; Keith L
    Clin Obstet Gynecol; 1982 Jun; 25(2):267-75. PubMed ID: 6179676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
    Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
    Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions.
    Dunbar NM; Katus MC; Freeman CM; Szczepiorkowski ZM
    Transfusion; 2015 Aug; 55(8):1882-8. PubMed ID: 25757728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive anti-C acquired in the setting of Rh immune globulin administration following Rh mismatched apheresis platelet transfusion: A case series.
    Sostin N; Ross R; Balbuena-Merle R; Hendrickson JE; Tormey CA
    J Clin Apher; 2020 Jun; 35(3):224-226. PubMed ID: 32110829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients.
    Asfour M; Narvios A; Lichtiger B
    MedGenMed; 2004 Jul; 6(3):22. PubMed ID: 15520646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective surveillance of D- recipients of D+ apheresis platelets: alloimmunization against D is not detected.
    Weinstein R; Simard A; Ferschke J; Vauthrin M; Bailey JA; Greene M
    Transfusion; 2015 Jun; 55(6):1327-30. PubMed ID: 25523100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of anti-D alloimmunization in D-negative individuals receiving D-positive red blood cell transfusion: A systematic review and meta-analysis.
    Ji Y; Luo G; Fu Y
    Vox Sang; 2022 May; 117(5):633-640. PubMed ID: 35014050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.